Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-025505

CHIEF OPERATING OFFICER sold 716 shares at $30.00 ($21,483)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · CHIEF OPERATING OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-18 Sale : show line 1 in the form 10b5-1 −716 $30.00 $21,483 343,311 I
Open-market sales · 716 sh · avg $30.00 · $21,483
Loading xslF345X05/form4-10222024_081006.xml…